Concepedia

Markus Langen

ML

2

Publications

25

Citations

2

H-Index

2017

Active since

Affiliations

Praxis für Hämatologie und Onkologie(Current)

Bayer (Germany)

University Medical Center Hamburg-Eppendorf

Statistisches Bundesamt

Universität Hamburg

Markus Langen is an author at Praxis für Hämatologie und Onkologie specializing in surgical oncology, outcomes research, and surgery.

Top concepts

SurgeryMedicineOncologyPublic HealthCancer ResearchClinical TrialsPharmacotherapyGastroenterologyClinical EfficacyColorectal Cancer

Publications per year

2017–2018

2

Publications

2

Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Final results of the prospective multicentre non-interventional RECORA study.

H. Schulz, U.P. Strauss, Markus Langen et al. · Journal of Clinical Oncology · 2018 · 15 citations

Surgical Oncology, Colorectal Surgery, Cancer Management +24

Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Interim results of the prospective multicentre noninterventional RECORA study.

H. Schulz, U.P. Strauss, Markus Langen et al. · Journal of Clinical Oncology · 2017 · 10 citations

Baseline Ecog Ps, Surgical Oncology, Cancer Management +23

Rows per page

1–2 of 2